All In MedTech

Device Trial Radar · NCT00180297

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Evaluation of the Success Rate and the Clinical Evolution of a Ventricular Lead Implanted in the Septum Versus the Right Ventricular Apex.

Last checked: Nov 20, 2026Latest source record: Oct 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 215 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

215

Actual

Start

Apr 2005

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
Collaborators
Guidant Corporation
First posted
Sep 16, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the safety and efficacy of the implant of a ICD lead of defibrillation in the septum of the right ventricle

Conditions

  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

  • Endotak Reliance GDevice

    Reliance G is a defibrillation lead to be placed in the right ventricle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Implant Success Rate at Septal SiteTime frame: At implant

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • CH Amiens

    Amiens, France

  • CHU Angers

    Angers, France

  • CH Besancon

    Besançon, France

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.